Special considerations in immunotherapy trials Book Section


Authors: Friedman, C. F.; Panageas, K. S.; Wolchok, J. D.
Editors: Kelly, W. K.; Halabi, S.
Article/Chapter Title: Special considerations in immunotherapy trials
Keywords: melanoma; advanced; monoclonal-antibody; phase-i; adverse events; open-label; clinical activity; immune-related response; anti-pd-l1 antibody; pd-1 blockade; nivolumab plus ipilimumab
Book Title: Oncology Clinical Trials: Successful Design, Conduct, and Analysis. 2nd ed
ISBN: 978-0-8261-6873-3
Publisher: Demos Medical Publications  
Publication Place: New York, NY
Date Published: 2018-01-01
Start Page: 399
End Page: 409
Language: English
ACCESSION: WOS:000482770900044
PROVIDER: wos
DOI: 10.1891/9780826168733
Notes: Book Chapter: 42 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Katherine S Panageas
    512 Panageas
  3. Claire Frances Friedman
    117 Friedman